WNT16 and cartilage changes in hip osteoarthritis
WNT signaling in chondrocyte biology and osteoarthritis
['FUNDING_R01'] · UNIVERSITY OF ROCHESTER · NIH-11175968
This work looks at whether the protein WNT16 helps cartilage cells resist damage and could slow hip osteoarthritis in people with hip impingement.
Quick facts
| Phase | ['FUNDING_R01'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | UNIVERSITY OF ROCHESTER (nih funded) |
| Locations | 1 site (ROCHESTER, UNITED STATES) |
| Trial ID | NIH-11175968 on ClinicalTrials.gov |
What this research studies
Researchers compare cartilage from people with symptomatic femoroacetabular impingement (FAI) and hip osteoarthritis to measure WNT16 levels and related signals. They grow human stem cell–derived and primary hip chondrocytes in agarose gels and apply mechanical loading while turning TRPV4 activity up or down. The team will study genetic and epigenetic switches that turn WNT16 on with loading and test how WNT16 affects chondrocyte hypertrophy through G protein–linked signaling. The work uses human cartilage samples and lab-grown human cartilage cells to link how mechanical forces and a mechanosensor (TRPV4) control WNT16 in cells relevant to hip OA.
Who could benefit from this research
Good fit: Ideal candidates would be people with symptomatic femoroacetabular impingement (FAI) or early hip osteoarthritis, especially those undergoing hip evaluation or surgery where cartilage can be sampled.
Not a fit: People without hip joint disease or those with very advanced joint damage where cartilage is already lost are unlikely to benefit directly from this mechanistic work.
Why it matters
Potential benefit: If successful, this could point to new ways to protect cartilage cells and slow or prevent progression of hip osteoarthritis.
How similar studies have performed: Prior studies link lower WNT16 to worse osteoarthritis and show TRPV4 senses load in cartilage, but connecting TRPV4-driven WNT16 regulation in human hip OA is a new direction.
Where this research is happening
ROCHESTER, UNITED STATES
- UNIVERSITY OF ROCHESTER — ROCHESTER, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: WU, CHIA-LUNG — UNIVERSITY OF ROCHESTER
- Study coordinator: WU, CHIA-LUNG
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.